Rachel Kremen
Journalist
Freelance
From this contributor
Funds add up for research plans that put focus on families
With billions of dollars in hand, a novel initiative is funding projects that involve people with disorders and their caregivers from the outset.
Funds add up for research plans that put focus on families
Companies see upside of hiring people with autism
As the prevalence of autism grows, several companies are launching employment programs for people on the spectrum.
Standard tests underestimate nonverbal children with autism
Tests that play to the strengths of nonverbal children with autism reveal the true intellect of those considered ‘low-functioning.’
Standard tests underestimate nonverbal children with autism
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.